CYTK
Cytokinetics Inc.
$82.62
0.84%
+0.69
Notify me if price changes either direction
Buy CYTK stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
11.2B
Enterprise value
10.9B
Trailing PE
-12.629969185645
Forward PE
-17.44364
PEG Ratio
-0.55408897072509
Enterprise to EBITDA
-17.262
Enterprise to revenue
102.617
Price to book MRQ
-12.318828713307
Price to sales TTM
104.533676
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2026-03-31
Revenue (TTM)
105.8M
EBITDA
-629041984
Diluted EPS TTM
-6.85
Total Cash (MRQ)
818.6M
Current ratio (MRQ)
4.214
Operating Cash Flow (TTM)
-523848992
CYTK trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
July 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
